Firstly, drug protonation significantly reduces binding to phospholipid membranes (Visudyne, Ambisome, Mepact) and even drastically alters the morphology and vesicle size in multivesicular liposomes (Exparel)
1 Sunvold GD, Tetrick MA, Davenport GM, Bouchard GF
When you embark on a weight loss program at Hopkins MD, we may use GLP-1 agonists to support your journey
High molecular weight, might influence protein function and downstream experiments
The results highlight biological processes, molecular functions, or cellular components most relevant to the experimental condition, providing structured insights for interpretation of omics datasets
These include: Neuroprotection : Reducing oxidative stress and inflammation that contribute to dopaminergic neuron death Mitochondrial support : Enhancing cellular energy production, which is often impaired in Parkinson's Protein clearance : Potentially improving the removal of toxic protein aggregates like alpha-synuclein Metabolic benefits : Addressing insulin resistance and glucose dysregulation, which may influence neurodegeneration However, these potential advantages must be weighed against known adverse effects of GLP-1 receptor agonists